Protalix BioTherapeutics Reports Third Quarter 2021 Financial Results and Provides Financial and Business Update
Go back to Protalix BioTherapeutics Reports Third Quarter 2021 Financial Results and Provides Financial and Business Update| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.16 | 52 Week High | $1.11 | |||
| Open | $2.16 | 52 Week Low | $0.41 | |||
| Day High | $2.16 | P/E | N/A | |||
| Day Low | $2.16 | EPS | $-0.29 | |||
| Volume | 5,346 | |||||
| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.16 | 52 Week High | $1.11 | |||
| Open | $2.16 | 52 Week Low | $0.41 | |||
| Day High | $2.16 | P/E | N/A | |||
| Day Low | $2.16 | EPS | $-0.29 | |||
| Volume | 5,346 | |||||

